Hybrid plasmid pzzsa coding the synthesis of angiogenis of angiogenin protein and escherichia coli bl21(des) pzzsa strain as the the superoducer of the recombinant chimeric protein of human angiogenin

摘要

The invention relates to biotechnology and enhances the expression efficiency of the hybrid gene and stability of the angiogenin protein, as well as provides a possibility of affinity purification of chimeric protein on IgG sorbents. The hybrid plasmid pZZSA with a molecular weight of 3.814 megadalton (MDa) (6192 bp) which drives the synthesis of the chimeric protein of angiogenin is disclosed, comprising an XhoI/EcoRI fragment of the pGM280 plasmid DNA comprising a tandem of E. coli tryptophan operon promoters, a lambda phage transcription terminator, a beta-lactamase gene and an ori replication initiation site; an EcoRI/EcoNI fragment of the PfM plasmid comprising a synthetic translation enhancer of the bacteriophage T7 gene and gene Ap coding for the amino acid sequence corresponding to 3988-4845 bp; synthetic chimeric angiogenin gene (Ang) fused with Spa; unique recognition sites for restriction nucleases. The strain Escherichia coli BL21 (DE3) pZZSA (the Collection of Microorganisms of the Interregional Center for Human Microcenosis Correction, Novosibirsk, Registration No. MCKM B-127) that is the superproducer of recombinant chimeric protein of human angiogenin is described.